Schoepfer J, Gay B, Caravatti G, Garcia-Echeverria C, Fretz H, Rahuel J, Furet P
Novartis Pharma Inc., Oncology Research Department, Basle, Switzerland.
Bioorg Med Chem Lett. 1998 Oct 20;8(20):2865-70. doi: 10.1016/s0960-894x(98)00513-7.
We have designed and synthesized a (3-aminomethyl-phenyl)-urea scaffold to mimic the X+1-Asn part of the minimal phosphopeptide sequence, Ac-pTyr-X+1-Asn-NH2, recognized by the Grb2-SH2 domain. The resulting compounds show the same degree of affinity as their peptide counterparts for the Grb2-SH2 domain. This is the first example reported to date of ligands of the Grb2-SH2 domain with substantially reduced peptidic character.
我们设计并合成了一种(3-氨甲基-苯基)-脲支架,以模拟被Grb2-SH2结构域识别的最小磷酸肽序列Ac-pTyr-X +1-Asn-NH2中的X +1-Asn部分。所得化合物对Grb2-SH2结构域显示出与相应肽相同程度的亲和力。这是迄今为止报道的具有显著降低肽性的Grb2-SH2结构域配体的首个实例。